This is the video recording of the February 9, 2024, Hot Corner Insider Weekly Strategy Session.
Venrock Healthcare Reports a $1.2 Million KALV Buy
From the Desk of Steve Strazza and Alfonso Depablos
The most significant transaction on today’s list comes in a Form 4 filing by Venrock Healthcare Capital Partners.
The firm reported a purchase of roughly $1.2 million in KalVista Pharmaceuticals Inc $KALV.
Magnolia Capital Reports a $2.5 Million CRMT Buy
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Magnolia Capital Fund.
The investment firm revealed a purchase of $2.5 million in America’s Car-Mart Inc $CRMT.
Director Nanji Reports a $15 Million RXO Purchase
From the Desk of Steve Strazza and Alfonso Depablos
The most significant transaction on today’s list comes in a Form 4 filing by Farhad Nanji, director at RXO Inc $RXO.
Nanji revealed a purchase of 747,424 RXO shares, equivalent to $15 million.
Buffett and Berkshire Are Back for More OXY
From the Desk of Steve Strazza and Alfonso Depablos
The most significant transaction on today’s list comes in a Form 4 filing by Warren Buffett and Berkshire Hathaway.
Buffett and Berkshire reported another substantial purchase in Occidental Petroleum Corp $OXY, this time with a total value of $245 million.
Buffett and Berkshire Report a $55 Million Liberty SiriusXM Buy
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes via Form 4 filings by Warren Buffett and Berkshire Hathaway.
Buffett and Berkshire reported additional purchases in The Liberty SiriusXM Group for a total amount of $55,438,736.
Director Katabi Reports a $5 Million VERA Purchase
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a series of Form 4 filings by Maha Katabi, director of Vera Therapeutics $VERA.
Katabi reported a purchase of 161,290 VERA shares, equivalent to $5 million.
Gilead Reports a $320 Million RCUS Buy, Raises Its Stake to 40%
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a series of Form 4 filings by Gilead Sciences.
The American biopharmaceutical company revealed a purchase of roughly $320 million in Arcus Biosciences Inc $RCUS, increasing its ownership stake to 40%.
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 90
- Next Page »